A team of researchers led by Kwang W. Oh, PhD, associate professor of biomedical engineering and electrical engineering, has fabricated a chip that uses two different types of force — capillary- and vacuum-driven — to manipulate how fluids travel in micro- and nanosized channels.
Three Jacobs School of Medicine and Biomedical Sciences faculty members performed surgeries that were broadcast live to the Vascular Interventional Advances (VIVA) Conference in Las Vegas.
Steven J. Fliesler, PhD, has been appointed editor-in-chief of Experimental Eye Research and also has received the Dean’s Award in Neuroscience and Ophthalmology from Louisiana State University (LSU) Health Sciences Center New Orleans.
Cytocybernetics, a UB spinoff co-founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has been awarded $1.5 million by the National Institutes of Health (NIH) to develop an enhanced version of a device it created that integrates electronics with heart muscle cells to test how new drugs affect the heart’s electrical activity.
Adnan Siddiqui, MD, PhD, vice chair and professor of neurosurgery and one of the lead investigators in the COMPASS trial, presented preliminary results at the International Stroke Conference in Los Angeles that show evidence that aspiration-based thrombectomy is a safe and effective alternative for patients with acute ischemic stroke.
A new review paper led by Stephanie Anzman-Frasca, PhD, assistant professor of pediatrics, suggests varied diets and persistence in exposing infants and children to healthy foods is key to promoting healthy eating behaviors.
University at Buffalo spinoff POP Biotechnologies Inc. (POP BIO) ended 2017 on a high note with a flurry of activity, including reaching research agreements with two international pharmaceutical companies.
Beth A. Smith, MD ’00, clinical associate professor of psychiatry and division chief of child and adolescent psychiatry, has been awarded the 2017 Carolyn and C. Richard Mattingly Leadership in Mental Health Care Award by the Cystic Fibrosis Foundation.
The Western New York community has enlisted experts from the Jacobs School of Medicine and Biomedical Sciences to help combat the national opioid epidemic, which has reached crisis proportions.
Research by lead author Michal K. Stachowiak, PhD, has revealed that schizophrenia likely begins toward the end of the first trimester of pregnancy — a finding that opens up a new understanding of the devastating disease and the potential for new treatment possibilities in utero.
Xiaozhong Wen, PhD, has led a pilot study to test an innovative method of smoking cessation during pregnancy and examine the correlation between maternal smoking and childhood obesity.
The value of interprofessional collaboration in dealing with the opioid crisis was highlighted as students and staff from the Jacobs School of Medicine and Biomedical Sciences joined other UB schools of study during a forum on opioid dependence.
New clues to non-alcoholic fatty liver disease (NAFLD), which affects nearly all obese adults and a rising percentage of obese children, have been reported in a paper by senior author Susan S. Baker MD, PhD.
Anne B. Curtis, MD, SUNY Distinguished Professor and Charles and Mary Bauer Professor and chair of the Department of Medicine, is a member of the committee that has issued a new practice guideline for treating sudden cardiac death (SCD).
Four studies focused on improving our understanding of the human genome and microbiome have been awarded funding through the third round of research pilots supported by the Community of Excellence in Genome, Environment and Microbiome (GEM).
Jun Xia, PhD, assistant professor of biomedical engineering, has been awarded a $450,000 grant that will help improve screening for women with dense breast tissue.
A new book co-edited by Mulchand S. Patel, PhD, SUNY Distinguished Professor of biochemistry, discusses how the path to obesity may start before birth or during infancy and how an individual’s metabolism can be permanently reprogrammed by overfeeding early in life.
A newly patented technology developed as a collaboration in the departments of Biomedical Engineering, Orthopaedics, and Microbiology and Immunology is at the heart of an Office of Naval Research (ONR) grant focused on preventing and treating orthopaedic implant-related infections.
The Jacobs School of Medicine and Biomedical Sciences (JSMBS) hosted a conference to discuss recent progress and future trends in the rapidly evolving field of complementology.
A global study led by Paresh Dandona, MD, PhD, found a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels.
